Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

How I treat autoimmune lymphoproliferative syndrome.

Rao VK, Oliveira JB.

Blood. 2011 Nov 24;118(22):5741-51. doi: 10.1182/blood-2011-07-325217. Epub 2011 Sep 1. Review.

2.

Advances in autoimmune lymphoproliferative syndromes.

Madkaikar M, Mhatre S, Gupta M, Ghosh K.

Eur J Haematol. 2011 Jul;87(1):1-9. doi: 10.1111/j.1600-0609.2011.01617.x. Review.

PMID:
21447005
3.

[Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].

Garrido Colino C.

An Pediatr (Barc). 2014 Feb;80(2):122.e1-7. doi: 10.1016/j.anpedi.2013.06.004. Epub 2013 Sep 20. Review. Spanish.

4.

Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).

Li P, Huang P, Yang Y, Hao M, Peng H, Li F.

Clin Rev Allergy Immunol. 2016 Feb;50(1):55-63. doi: 10.1007/s12016-015-8466-y. Review.

PMID:
25663566
5.

Autoimmune Lymphoproliferative Syndrome.

Bleesing JJH, Nagaraj CB, Zhang K.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.
2006 Sep 14 [updated 2017 Aug 24].

6.

Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.

Ries F, Ferster A, Rieux-Laucat F, Biwer A, Dicato M.

Bull Soc Sci Med Grand Duche Luxemb. 2010;(2):271-8.

PMID:
20882745
7.

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).

Teachey DT, Seif AE, Grupp SA.

Br J Haematol. 2010 Jan;148(2):205-16. doi: 10.1111/j.1365-2141.2009.07991.x. Epub 2009 Nov 23. Review.

8.

Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.

Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ.

Blood. 2014 Mar 27;123(13):1989-99. doi: 10.1182/blood-2013-10-535393. Epub 2014 Jan 7.

9.

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, Rieux-Laucat F, Siegel RM, Su HC, Teachey DT, Rao VK.

Blood. 2010 Oct 7;116(14):e35-40. doi: 10.1182/blood-2010-04-280347. Epub 2010 Jun 10.

10.

Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.

George LA, Teachey DT.

Paediatr Drugs. 2016 Aug;18(4):261-72. doi: 10.1007/s40272-016-0175-3. Review.

PMID:
27139496
11.

The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance.

Turbyville JC, Rao VK.

Autoimmun Rev. 2010 May;9(7):488-93. doi: 10.1016/j.autrev.2010.02.007. Epub 2010 Feb 17. Review.

PMID:
20170754
12.

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.

Dowdell KC, Niemela JE, Price S, Davis J, Hornung RL, Oliveira JB, Puck JM, Jaffe ES, Pittaluga S, Cohen JI, Fleisher TA, Rao VK.

Blood. 2010 Jun 24;115(25):5164-9. doi: 10.1182/blood-2010-01-263145. Epub 2010 Apr 1.

13.

[A case of autoimmune lymphoproliferactive syndrome and literature review].

Liu L, Hu J, Ma J, Li X, Li F, Li C.

Zhonghua Er Ke Za Zhi. 2014 Dec;52(12):923-6. Review. Chinese.

PMID:
25619350
14.

The expanding spectrum of the autoimmune lymphoproliferative syndromes.

Oliveira JB.

Curr Opin Pediatr. 2013 Dec;25(6):722-9. doi: 10.1097/MOP.0000000000000032. Review.

15.

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.

Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE.

Blood. 1997 Feb 15;89(4):1341-8.

16.

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.

Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W.

Ann Intern Med. 1999 Apr 6;130(7):591-601. Review.

PMID:
10189330
17.

Autoimmune lymphoproliferative syndrome: an update and review of the literature.

Shah S, Wu E, Rao VK, Tarrant TK.

Curr Allergy Asthma Rep. 2014 Sep;14(9):462. doi: 10.1007/s11882-014-0462-4. Review.

18.

Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis.

Rudman Spergel A, Walkovich K, Price S, Niemela JE, Wright D, Fleisher TA, Rao VK.

Pediatrics. 2013 Nov;132(5):e1440-4. doi: 10.1542/peds.2012-2748. Epub 2013 Oct 7.

19.

Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.

Ruiz-García R, Mora S, Lozano-Sánchez G, Martínez-Lostao L, Paz-Artal E, Ruiz-Contreras J, Anel A, González-Granado LI, Moreno-Pérez D, Allende LM.

Pediatr Res. 2015 Dec;78(6):603-8. doi: 10.1038/pr.2015.170. Epub 2015 Sep 3.

PMID:
26334989
20.

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).

Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T.

Pediatr Blood Cancer. 2009 Jul;52(7):847-52. doi: 10.1002/pbc.21965.

Supplemental Content

Support Center